The Cancer Campaigning Group (CCG) is a coalition of national cancer-related charities representing service providers, research, advocacy and campaigning groups for cancer patients and their families. Founded in 2002, it enables cancer charities to speak and campaign with a single unified voice.
The aim of the CCG is to campaign for improved cancer policy and services in the areas of prevention; care and treatment; patient involvement and choice; and research.
The CCG’s campaigning strategy and activities are developed by a steering group of representatives from six member charities – Cancer Research UK, Macmillan Cancer Support, Breast Cancer Campaign, The Roy Castle Lung Cancer Foundation, The Rarer Cancers Forum and The Prostate Cancer Charity. Luther Pendragon provides the Secretariat to the Group, including communications advice, support and implementation.
The CCG’s work is supported by five pharmaceutical companies – GlaxoSmithKline, Roche, Pfizer, Bristol-Myers-Squibb, Sanofi-Aventis - and one medical technology company, GE Healthcare . Supporting organisations do not direct or control CCG strategy, activities or literature in any way. The CCG ensures that all its relationships with supporter organisations comply with the Association of the British Pharmaceutical Industry (ABPI) code of conduct, governing the relationship between patient groups and pharmaceutical companies.
Kevin Barron MP speaks to CCG members on behalf of the Health Select Committee
Latest news
CCG Question Time Event
01 February 2010
CCG Question Time event on Wednesday 3rd March 2010.
Panelists includes Ann Keen MP, Mark Simmonds MP, Norman Lamb MP and Anna Dixon, Acting CEO of the King's Fund.
Read more »
European Commission to launch European Partnership for Action Against Cancer
22 September 2009
The European Commission will be launching the European Partnership for Action Against Cancer next Tuesday 29 September 2009 in Brussels. Read more »
Kennedy publishes Appraising the Value of Innovation report
22 July 2009
Professor Sir Ian Kennedy has published his study on Appraising the Value of Innovation, which was commissioned by NICE. Read more »
New Eurocancercoms Project
20 July 2009
The European Institute of Oncology has launched a £1m Eurocancercoms project which will improve links between hospitals, doctors, patient groups and the pharmaceutical industry by developing a new website. It is designed to improve the flow of information between stakeholders.
Read more »
The Cancer Campaigning Group is supported by six pharmaceutical companies:
